
10 000+ employés
💊 Pharmaceutique
🏥 Santé
🧬 Biotechnologie
💰 €6 500 000 Post-IPO Debt - Eli Lilly en 2024-02
Pharmaceuticals • Healthcare • Biotechnology
Eli Lilly and Company est une entreprise pharmaceutique mondiale qui recherche, développe, fabrique et distribue des médicaments sur ordonnance et propose des services de soutien aux patients. L'entreprise se concentre sur des médicaments révolutionnaires pour des maladies telles que le diabète, le cancer, la maladie d'Alzheimer, les maladies auto-immunes, la dermatologie, la migraine, l'obésité et l'apnée du sommeil ; elle mène des essais cliniques, offre des services pharmaceutiques LillyDirect et met l'accent sur la qualité de fabrication, la sécurité des médicaments et la recherche sur les médicaments génétiques. Eli Lilly propose également des ressources pour les patients, des formations sur les maladies et des programmes d'accès pour aider les personnes à trouver des soins et à participer à des essais.
🔥 il y a 6 heures
🗣️🇺🇸🇬🇧 Anglais requis
D'où vient cette offre
Publiée sur la page carrières de Eli Lilly and Company, pas via un site d'emploi
Repérée par Remote Rocketship il y a 6 heures
Toujours ouverte sur le site de Eli Lilly and Company. Vérifiée il y a 10 minutes.

10 000+ employés
💊 Pharmaceutique
🏥 Santé
🧬 Biotechnologie
💰 €6 500 000 Post-IPO Debt - Eli Lilly en 2024-02
Pharmaceuticals • Healthcare • Biotechnology
Eli Lilly and Company est une entreprise pharmaceutique mondiale qui recherche, développe, fabrique et distribue des médicaments sur ordonnance et propose des services de soutien aux patients. L'entreprise se concentre sur des médicaments révolutionnaires pour des maladies telles que le diabète, le cancer, la maladie d'Alzheimer, les maladies auto-immunes, la dermatologie, la migraine, l'obésité et l'apnée du sommeil ; elle mène des essais cliniques, offre des services pharmaceutiques LillyDirect et met l'accent sur la qualité de fabrication, la sécurité des médicaments et la recherche sur les médicaments génétiques. Eli Lilly propose également des ressources pour les patients, des formations sur les maladies et des programmes d'accès pour aider les personnes à trouver des soins et à participer à des essais.
• Provide clinical pharmacology and PK/PD input to project teams, contributing to decisions on dose, patient population, and study design • Conduct and interpret noncompartmental and population PK analyses for Phase 1–2 studies, including FIH, SAD/MAD, DDI, food effect, organ impairment, and patient studies • Develop structural models, evaluate covariates, and perform model diagnostics • Build and apply exposure–response and PK/PD analyses and PBPK models to support dose selection and drug–drug interaction risk assessment • Integrate nonclinical PK/PD, in vitro ADME data, and biomarker data to support human PK and dose projections, interspecies scaling, and first-in-human rationale • Draft PK/PD sections of clinical development plans, protocols, analysis plans, investigator brochures, study reports, and regulatory documents including IND, CTA, NDA, and MAA submissions • Collaborate with DMPK, translational sciences, clinical development, bioanalysis, biostatistics, regulatory affairs, and project leadership • Provide day-to-day scientific oversight of CRO and vendor deliverables • Participate in peer review of analyses and reports • Present findings to internal stakeholders and contribute to external scientific publications and presentations
• PhD or PharmD in Clinical Pharmacology, Pharmacometrics, Pharmacokinetics, Pharmaceutical Sciences, or a related discipline, or a graduate degree in these areas with a strong demonstrated work history • 3+ years of industry experience in clinical pharmacology or pharmacometrics within biotech, pharmaceutical, or drug development environments; relevant postdoctoral experience considered • Solid working knowledge of PK/PD theory, ADME, DDI mechanisms including in vitro-to-clinical translation, and MIDD principles • Hands-on proficiency with NONMEM, Phoenix WinNonlin/NLME, Monolix, R, or similar software • Ability to choose an appropriate analysis, troubleshoot model problems, and clearly explain a model's assumptions and limitations • Working knowledge of FDA, EMA, and ICH guidance relevant to clinical pharmacology, including ICH M12 and ICH M15 • Interest in translational medicine, including target engagement, biomarkers, and nonclinical-to-clinical translation • Ability to work effectively in cross-functional, matrixed environments • Excellent communication and stakeholder management skills • Exposure to PBPK platforms such as Simcyp, GastroPlus, or PK-Sim, or QSP modeling, is a plus • Curiosity, passion for the work, adaptability, problem-solving ability, growth mindset, and interest in artificial intelligence and digital innovation
• Company bonus depending in part on company and individual performance • Company-sponsored 401(k) • Pension • Vacation benefits • Medical benefits • Dental benefits • Vision benefits • Prescription drug benefits • Flexible benefits, including healthcare and/or dependent day care flexible spending accounts • Life insurance and death benefits • Time off and leave of absence benefits • Well-being benefits, including employee assistance program, fitness benefits, and employee clubs and activities • Employee resource groups open to all employees
Postuler MaintenantAméliorez vos chances d'obtenir un entretien en vérifiant votre score de CV avant de postuler.
🕒 il y a 7 jours
Clinical Expert Advisor helping Siemens Healthineers customers optimize healthcare workflows, quality, and costs. Leading performance-improvement engagements and project teams across clinical and operational settings.
🇺🇸 États-Unis – Télétravail
💵 $162 970 - $224 081 / an
💰 €1 500 000 Grant en 2021-05
⏰ Temps Plein
🟠 Senior
🔴 Expert
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 7 jours
Clinical Expert Advisor improving clinical, operational, and financial outcomes for Siemens Healthineers’ healthcare customers. Leading engagements, project teams, and performance-improvement initiatives.
🇺🇸 États-Unis – Télétravail
💵 $162 970 - $224 081 / an
💰 €1 500 000 Grant en 2021-05
⏰ Temps Plein
🟠 Senior
🔴 Expert
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 18 jours
Senior Clinical Pharmacology Advisor advancing Centessa’s orexin medicines through PK/PD modeling. Supporting clinical development, dose selection, and regulatory submissions.
🇺🇸 États-Unis – Télétravail
💵 $168 000 - $268 400 / an
💰 €6 500 000 Post-IPO Debt - Eli Lilly en 2024-02
⏰ Temps Plein
🟠 Senior
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 21 jours
Senior Advisor leading delivery of Massachusetts’s statewide vaccine management and clinical case management system. Translating local health department needs into product requirements, workflows, and adoption strategies.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 27 jours
Clinical science advisor guiding Lilly’s Orexin-targeted Phase 2–3 trials for sleep and wake disorders. Leading study science, data review, documentation, and cross-functional execution.
🇺🇸 États-Unis – Télétravail
💵 $153 000 - $283 800 / an
💰 €6 500 000 Post-IPO Debt - Eli Lilly en 2024-02
⏰ Temps Plein
🟠 Senior
🗣️🇺🇸🇬🇧 Anglais requis